January 08, 2020 2019 was all about execution for smaller device makers New products and strategic execution buoyed mid and small-cap medtechs, while safety worries took down one former high-flier.
October 15, 2019 Admedus moves from one unlikely area to another A product sale nets the Australian company some much-needed cash, but its plan for the future is highly questionable.
